Mitochondrial biogenesis in cardiac pathophysiology

Pharmacological Reports

Volumn 61, Issue 1, 2009, Pages 131-138

  Rimbaud, Stéphanie ^a,b   Garnier, Anne ^a,b   Ventura Clapier, Renée ^a,b  

^a Universite Paris Sud   (France)

^b IPSIT   (France)

Author keywords

Cardiac hypertrophy; Heart failure; Mitochondria; PGC 1

Indexed keywords

AEROBIC METABOLISM; BIOGENESIS; CONFERENCE PAPER; ENERGY METABOLISM; HEART DEVELOPMENT; HEART DISEASE; HEART FAILURE; HEART HYPERTROPHY; HEART MUSCLE; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HEART SIZE; HEART WORK; HUMAN; MITOCHONDRIAL RESPIRATION; NONHUMAN; PHYSIOLOGICAL STRESS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 66949139996     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70015-5     Document Type: Conference Paper

References (55)

1. Arany Z, He H, Lin J, Hoyer K, Handschin C, Toka O, Ahmad F et al.: Transcriptional coactivator PGC-1 alpha controls the energy state and contractile function of cardiac muscle. Cell Metab, 2005, 1, 259-271.
2. Baker MJ, Frazier AE, Gulbis JM, Ryan MT: Mitochondrial protein-import machinery: correlating structure with function. Trends Cell Biol, 2007, 17, 456-464.
3. Calvo S, Jain M, Xie X, Sheth SA, Chang B, Goldberger OA, Spinazzola A et al.: Systematic identification of human mitochondrial disease genes through integrative genomics. Nat Genet, 2006, 38, 576-582.
4. Chandler MP, Kerner J, Huang H, Vazquez E, Reszko A, Martini WZ, Hoppel CL et al.: Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol, 2004, 287, H1538-H1543.
5. Coleman R, Weiss A, Finkelbrand S, Silbermann M: Age and exercise-related changes in myocardial mitochondria in mice. Acta Histochem, 1988, 83, 81-90.
6. de Brouwer KF, Degens H, Aartsen WM, Lindhout M, Bitsch NJ, Gilde AJ, Willemsen PH et al.: Specific and sustained down-regulation of genes involved in fatty acid metabolism is not a hallmark of progression to cardiac failure in mice. J Mol Cell Cardiol, 2006, 40, 838-845.
7. De Sousa E, Veksler V, Bigard X, Mateo P, Ventura-Clapier R: Heart failure affects mitochondrial but not myofibrillar intrinsic properties of skeletal muscle. Circulation, 2000, 102, 1847-1853.
8. De Sousa E, Veksler V, Minajeva A, Kaasik A, Mateo P, Mayoux E, Hoerter J et al.: Subcellular creatine kinase alterations. Implications in heart failure. Circ Res, 1999, 85, 68-76.
9. Degens H, de Brouwer KF, Gilde AJ, Lindhout M, Willemsen PH, Janssen BJ, van der Vusse GJ, van Bilsen M: Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart. Basic Res Cardiol, 2006, 101, 17-26.
10. Dufour CR, Wilson BJ, Huss JM, Kelly DP, Alaynick WA, Downes M, Evans RM et al.: Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma. Cell Metab, 2007, 5, 345-356.
11. Finck BN: The PPAR regulatory system in cardiac physiology and disease. Cardiovasc Res, 2007, 73, 269-277.
12. Finck BN, Kelly DP: Peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1) regulatory cascade in cardiac physiology and disease. Circulation, 2007, 115, 2540-2548.
13. Garnier A, Fortin D, Delomenie C, Momken I, Veksler V, Ventura-Clapier R: Depressed mitochondrial transcription factors and oxidative capacity in rat failing cardiac and skeletal muscles. J Physiol, 2003, 551, 491-501.
14. Hood DA, Joseph AM: Mitochondrial assembly: protein import. Proc Nutr Soc, 2004, 63, 293-300.
15. Huss JM, Kelly DP: Nuclear receptor signaling and cardiac energetics. Circ Res, 2004, 95, 568-578.
16. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Fujii N, Miyazaki H, Kakinuma Y et al.: Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res, 2003, 26, 829-837.
17. Javadov S, Huang C, Kirshenbaum L, Karmazyn M: NHE-1 inhibition improves impaired mitochondrial permeability transition and respiratory function during postinfarction remodelling in the rat. J Mol Cell Cardiol, 2005, 38, 135-143.
18. Jullig M, Hickey AJ, Chai CC, Skea GL, Middleditch MJ, Costa S, Choong SY et al.: Is the failing heart out of fuel or a worn engine running rich? A study of mitochondria in old spontaneously hypertensive rats. Proteomics, 2008, 8, 2556-2572.
19. Kayar SR, Conley KE, Claassen H, Hoppeler H: Capillarity and mitochondrial distribution in rat myocardium following exercise training. J Exp Biol, 1986, 120, 189-199.
20. Kelly DP, Scarpulla RC: Transcriptional regulatory circuits controlling mitochondrial biogenesis and function. Genes Dev, 2004, 18, 357-368.
21. Kemi OJ, Hoydal MA, Haram PM, Garnier A, Fortin D, Ventura-Clapier R, Ellingsen O: Exercise training restores aerobic capacity and energy transfer systems in heart failure treated with losartan. Cardiovasc Res, 2007, 76, 91-99.
22. Kuo WW, Chu CY, Wu CH, Lin JA, Liu JY, Ying TH, Lee SD et al.: The profile of cardiac cytochrome c oxidase (COX) expression in an accelerated cardiachypertrophy model. J Biomed Sci, 2005, 12, 601-610.
23. Lai L, Leone TC, Zechner C, Schaeffer PJ, Kelly SM, Flanagan DP, Medeiros DM et al.: Transcriptional coactivators PGC-1alpha and PGC-lbeta control overlapping programs required for perinatal maturation of the heart. Genes Dev, 2008, 22, 1948-1961.
24. LaPier TL, Rodnick KJ: Changes in cardiac energy metabolism during early development of female SHR. Am J Hypertens, 2000, 13, 1074-1081.
25. Lehman JJ, Barger PM, Kovacs A, Saffitz JE, Medeiros DM, Kelly DP: Peroxisome proliferator-activated receptor gamma coactivator-1 promotes cardiac mitochondrial biogenesis. J Clin Invest, 2000, 106, 847-856.
26. Lehman JJ, Boudina S, Banke NH, Sambandam N, Han X, Young DM, Leone TC et al.: The transcriptional coactivator PGC-1alpha is essential for maximal and efficient cardiac mitochondrial fatty acid oxidation and lipid homeostasis. Am J Physiol Heart Circ Physiol, 2008, 295, H185-H196.
27. Lehman JJ, Kelly DP: Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth. Heart Fail Rev, 2002, 7, 175-185.
28. Lehman JJ, Kelly DP: Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart. Clin Exp Pharmacol Physiol, 2002, 29, 339-345.
29. Lelliott CJ, Medina-Gomez G, Petrovic N, Kis A, Feldmann HM, Bjursell M, Parker N et al.: Ablation of PGC-1beta results in defective mitochondrial activity, thermogenesis, hepatic function, and cardiac performance. PLoS Biol, 2006, 4, e369.
30. Leone TC, Lehman JJ, Finck BN, Schaeffer PJ, Wende AR, Boudina S, Courtois M et al.: PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis. PLoS Biol, 2005, 3, e101.
31. Marin-Garcia J, Goldenthal MJ, Moe GW: Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure. Cardiovasc Res, 2001, 52, 103-110.
32. Matlib MA, Rembert JC, Millard RW, Ashraf M, Rouslin W, Asano G, Greenfield JC, Jr., Schwartz A: Mitochondrial function in canine experimental cardiac hypertrophy. J Mol Cell Cardiol, 1983, 15, 221-232.
33. Meirhaeghe A, Crowley V, Lenaghan C, Lelliott C, Green K, Stewart A, Hart K et al.: Characterization of the human, mouse and rat PGC1 beta (peroxisome-proliferator-activated receptor-gamma co-activator 1 beta) gene in vitro and in vivo. Biochem J, 2003, 373, 155-165.
34. Mettauer B, Zoll J, Garnier A, Ventura-Clapier R: Heart failure: a model of cardiac and skeletal muscle energetic failure. Pflugers Arch, 2006, 452, 653-666.
35. Murakami T, Shimomura Y, Fujitsuka N, Sugiyama S: Differential adaptation to endurance training between heart and gastrocnemius muscle mitochondria in rats. Biochem Mol Biol Int, 1995, 36, 285-290.
36. Nishio ML, Ornatsky OI, Craig EE, Hood DA: Mitochondrial biogenesis during pressure overload induced cardiac hypertrophy in adult rats. Can J Physiol Pharmacol, 1995, 73, 630-637.
37. Puigserver P, Spiegelman BM: Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr Rev, 2003, 24, 78-90.
38. Sack MN, Kelly DP: The energy substrate switch during development of heart failure: gene regulatory mechanisms (Review). Int J Mol Med, 1998, 1, 17-24.
39. Scarpulla RC: Transcriptional paradigms in mammalian mitochondrial biogenesis and function. Physiol Rev, 2008, 88, 611-638.
40. Sebastiani M, Giordano C, Nediani C, Travaglini C, Borchi E, Zani M, Feccia M et al.: Induction of mitochondrial biogenesis is a maladaptive mechanism in mitochondrial cardiomyopathies. J Am Coll Cardiol, 2007, 50, 1362-1369.
41. Sharov VG, Goussev A, Lesch M, Goldstein S, Sabbah HN: Abnormal mitochondrial function in myocardium of dogs with chronic heart failure. J Mol Cell Cardiol, 1998, 30, 1757-1762.
42. Sharov VG, Todor AV, Silverman N, Goldstein S, Sabbah HN: Abnormal mitochondrial respiration in failed human myocardium. J Mol Cell Cardiol, 2000, 32, 2361-2367.
43. St-Pierre J, Lin J, Krauss S, Tarr PT, Yang R, Newgard CB, Spiegelman BM: Bioenergetic analysis of peroxisome proliferator-activated receptor gamma coactivators 1alpha and 1beta (PGC-1alpha and PGC-1beta) in muscle cells. J Biol Chem, 2003, 278, 26597-26603.
44. Strom CC, Aplin M, Ploug T, Christoffersen TE, Langfort J, Viese M, Galbo H et al.: Expression profiling reveals differences in metabolic gene expression between exercise-induced cardiac effects and maladaptive cardiac hypertrophy. FEBS J, 2005, 272, 2684-2695.
45. Stuewe SR, Gwirtz PA, Agarwal N, Mallet RT: Exercise training enhances glycolytic and oxidative enzymes in canine ventricular myocardium. J Mol Cell Cardiol, 2000, 32, 903-913.
46. Sun CK, Chang LT, Sheu JJ, Wang CY, Youssef AA, Wu CJ et al.: Losartan preserves integrity of cardiac gap junctions and PGC-1 alpha gene expression and prevents cellular apoptosis in remote area of left ventricular myocardium following acute myocardial infarction. Int Heart J, 2007, 48, 533-546.
47. Terblanche SE, Gohil K, Packer L, Henderson S, Brooks GA: The effects of endurance training and exhaustive exercise on mitochondrial enzymes in tissues of the rat (Rattus norvegicus). Comp Biochem Physiol A Mol Integr Physiol, 2001, 128, 889-896.
48. van den Bosch BJ, Lindsey PJ, van den Burg CM, van der Vlies SA, Lips DJ, van der Vusse GJ, Ayoubi TA et al.: Early and transient gene expression changes in pressure overload-induced cardiac hypertrophy in mice. Genomics, 2006, 88, 480-488.
49. Vega RB, Huss JM, Kelly DP: The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol, 2000, 20, 1868-1876.
50. Ventura-Clapier R, Garnier A, Veksler V: Transcriptional control of mitochondrial biogenesis: the central role of PGC-1α. Cardiovasc Res, 2008, 79, 208-217.
51. Wagner RA, Tabibiazar R, Powers J, Bernstein D, Quertermous T: Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses. J Mol Cell Cardiol, 2004, 37, 1159-1170.
52. Watson PA, Reusch JE, McCune SA, Leinwand LA, Luckey SW, Konhilas JP, Brown DA et al.: Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol, 2007, 293, H246-H259.
53. Wiesner RJ, Aschenbrenner V, Ruegg JC, Zak R: Coordination of nuclear and mitochondrial gene expression during the development of cardiac hypertrophy in rats. Am J Physiol, 1994, 267, C229-C235.
54. Witt H, Schubert C, Jaekel J, Fliegner D, Penkalla A, Tiemann K, Stypmann J et al.: Sex-specific pathways in early cardiac response to pressure overload in mice. J Mol Med, 2008, 86, 1013-1024.
55. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A et al.: Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell, 1999, 98, 115-124.